Escot C - Search Results

1

Spontaneous apoptosis in the intra-ductal component's stroma of breast invasive carcinoma.

Rouleau-Dubois C, Cuny M, Ferrieres G, Simony-Lafontaine J, Rouanet P, Grenier J, Jeanteur P, Baldet P, Escot C. Rouleau-Dubois C, et al. Among authors: escot c. Anticancer Res. 2004 Jan-Feb;24(1):53-7. Anticancer Res. 2004. PMID: 15015575 Free article.

2

Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors.

Zhao Y, Escot C, Maudelonde T, Puech C, Rouanet P, Rochefort H. Zhao Y, et al. Among authors: escot c. Cancer Res. 1993 Jun 15;53(12):2901-5. Cancer Res. 1993. PMID: 7684951

3

Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas.

Ferrières G, Cuny M, Simony-Lafontaine J, Jacquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P, Escot C. Ferrières G, et al. Among authors: escot c. J Pathol. 1997 Oct;183(2):204-11. doi: 10.1002/(SICI)1096-9896(199710)183:2<204::AID-PATH921>3.0.CO;2-M. J Pathol. 1997. PMID: 9390034

4

Potential value of increased MYC but not ERBB2 RNA levels as a marker of high-risk mastopathies.

Escot C, Simony-Lafontaine J, Maudelonde T, Puech C, Pujol H, Rochefort H. Escot C, et al. Oncogene. 1993 Apr;8(4):969-74. Oncogene. 1993. PMID: 8455947

5

Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.

Le Roy X, Escot C, Brouillet JP, Theillet C, Maudelonde T, Simony-Lafontaine J, Pujol H, Rochefort H. Le Roy X, et al. Among authors: escot c. Oncogene. 1991 Mar;6(3):431-7. Oncogene. 1991. PMID: 1707153

6

Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.

Theillet C, Le Roy X, De Lapeyrière O, Grosgeorges J, Adnane J, Raynaud SD, Simony-Lafontaine J, Goldfarb M, Escot C, Birnbaum D. Theillet C, et al. Among authors: escot c. Oncogene. 1989 Jul;4(7):915-22. Oncogene. 1989. PMID: 2474139

7

In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer.

Maudelonde T, Escot C, Pujol P, Rouanet P, Defrenne A, Brouillet JP, Rochefort H. Maudelonde T, et al. Among authors: escot c. Eur J Cancer. 1994;30A(14):2049-53. doi: 10.1016/0959-8049(94)00343-4. Eur J Cancer. 1994. PMID: 7857701

8

The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis.

Mils V, Piette J, Barette C, Veyrune J, Tesnière A, Escot C, Guilhou JJ, Basset-Séguin N. Mils V, et al. Among authors: escot c. Oncogene. 1997 Apr 3;14(13):1555-61. doi: 10.1038/sj.onc.1200991. Oncogene. 1997. PMID: 9129146

9

In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast.

Mariani-Costantini R, Escot C, Theillet C, Gentile A, Merlo G, Lidereau R, Callahan R. Mariani-Costantini R, et al. Among authors: escot c. Cancer Res. 1988 Jan 1;48(1):199-205. Cancer Res. 1988. PMID: 2825967

These tumors have previously been examined by Southern and Northern blot analysis for the genomic status of c-myc and its expression, respectively (Escot et al., Proc. Natl. Acad. Sci. USA, 83: 4834-4838, 1986). Positive c-myc hybridization signals were assoc …

These tumors have previously been examined by Southern and Northern blot analysis for the genomic status of c-myc and its expression, …

10

Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.

Escot C, Zhao Y, Puech C, Rochefort H. Escot C, et al. Breast Cancer Res Treat. 1996;38(2):217-26. doi: 10.1007/BF01806676. Breast Cancer Res Treat. 1996. PMID: 8861840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters